Sort by
Refine Your Search
-
. The successful candidate will be joining the Atomic Quantum Optics group led by Prof. Dr. Morgan Mitchell, in an experiment on the interaction of single photons and entangled photon pairs with individual trapped
-
. The CRG is composed by an interdisciplinary, motivated and creative scientific team which is supported both by a flexible and efficient administration and by high-end and innovative technologies. In April
-
well as significant experience in at least two of the following areas: -Structural Biology -Characterization of biomolecule-small molecule interactions using biophysical techniques -Molecular Biology and Biochemistry
-
are interested in exploring a particularly intriguing one: the SU(N) Fermi-Hubbard model. It describes fermions of spin N and SU(N)-symmetric interactions, for which intricate magnetic orders and exotic spin
-
for information and communication technologies, in particular displays, image sensors and secure communications. The main drive of the group is to carry out applied research which bridges academia and industry, by
-
transfer and clinical translation. Industry Interaction: Specific experience in collaboration with companies and participation in co-development projects. Publications and Presentations: A track record of
-
transfer and clinical translation. Industry Interaction: Specific experience in collaboration with companies and participation in co-development projects. Publications and Presentations: A track record of
-
interact with co-workers promptly and professionally, management and support the wide user community of students, post-doctoral researchers and faculty, promoting the growth of the EM core. Excellent oral
-
. The CRG is composed by an interdisciplinary, motivated and creative scientific team which is supported both by a flexible and efficient administration and by high-end and innovative technologies. In April
-
challenge leadership decisions,” he notes. CIMR’s reforms, including reshaping the interaction between clinical management and scientific directors, to engage hospital leaders. Zhu will continue to focus